国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
DEXAMETHASONE PHOSPHATE
NewLine Pharma, S.L.
S01BA01
DEXAMETHASONE PHOSPHATE
1.37 milligram(s)/millilitre
Eye drops, solution in single-dose container
dexamethasone
Not marketed
2020-11-27
2 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT DEXAMETHASONE PHOSPHATE NEWLINE PHARMA 1.37 MG/ML EYE DROPS, SOLUTION IN SINGLE DOSE CONTAINER dexamethasone sodium phosphate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Dexamethasone phosphate NewLine Pharma is and what it is used for 2. What you need to know before you use Dexamethasone phosphate NewLine Pharma 3. How to use Dexamethasone phosphate NewLine Pharma 4. Possible side effects 5. How to store Dexamethasone phosphate NewLine Pharma 6. Contents of the pack and other information 1. WHAT DEXAMETHASONE PHOSPHATE NEWLINE PHARMA IS AND WHAT IT IS USED FOR Dexamethasone phosphate NewLine Pharma contains a substance called dexamethasone. It is a corticosteroid which inhibits inflammatory symptoms. It is indicated for the treatment of non-infectious inflammation of your eye(s) such as the conjunctiva, the eyelid and/or the white part of the eye. Tell your doctor if your condition does not improve after your prescribed length of treatment or if it worsens. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE DEXAMETHASONE PHOSPHATE NEWLINE PHARMA DO NOT USE DEXAMETHASONE PHOSPHATE NEWLINE PHARMA: - if you are allergic to the active substance or any of the other ingredients of this medicine (listed in section 6). - if you have high pressure inside the eye (ocular hypertension) - if you have eye infection such as herpes simplex, viral infections of the cornea at ulcerous stage, tuberculosis or mycosis of the eye, acute purulent ophthalmia, purulent conjunctiv 阅读完整的文件
Health Products Regulatory Authority 22 November 2021 CRN00C6NY Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dexamethasone phosphate NewLine Pharma 1.37 mg/ml eye drops, solution in single dose container 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml of solution contains 1.37 mg dexamethasone phosphate equivalent to 1.5 mg dexamethasone sodium phosphate. Each single-dose container of 0.3 ml contains 8.3 drops of 36 microlitres. Each drop contains 54 micrograms dexamethasone sodium phosphate. Excipients with known effect: 1 ml of solution contains 1.465 mg monobasic sodium phosphate monohydrate and 10 mg disodium phosphate dodecahydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution Clear and colourless solution, practically free from particles. pH: 6.7 – 7.7 Osmolality: 0.270 – 0.320 Osmol/kg 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dexamethasone phosphate NewLine Pharma is indicated for the treatment of steroid responsive, non-infectious, inflammatory conditions of the anterior segment of the eye. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dose is one drop of Dexamethasone phosphate NewLine Pharma into the conjunctival sac three to four times daily. The dose may be adjusted according to clinical requirements. _Paediatric population_ _ _ The safety and efficacy have not been established in the paediatric population. No data are available. Long-term continuous corticosteroid therapy should be avoided due to possible adrenal suppression (see section 4.4). Method of administration For ocular use only. The solution from one individual single dose container is to be used to the affected eye(s) immediately after opening for administration. Patients should be informed of the correct handling of the single-dose container. Instructions for use Patients should be informed of the correct handling of the single-dose container. 1. Wash hands thoroughly before putting in the eye drops. 2. Make sure the single-dose co 阅读完整的文件